Axichem shares decline 10% following 40% drop in quarterly net sales

Axichem reported a 40% decline in net sales and an increased operating loss in its latest interim report. The market reacted with a 10% sell-off on the Nasdaq First North exchange, reflecting investor concern over the company's deteriorating financial performance.